Lexicon Pharmaceuticals, Inc. [LXRX] saw a change by -9.49% with the trading session, closing the trade at the price of $3.19. The company is holding 107.17M shares with keeping 105.23M floating shares. With the latest trading session, the stock is set at 184.00% off compared to its 52-week low, sliding -61.92% from high for the same period of time.

Since its 90-day high, the share price saw a move by -25.17%, trading +164.34% in oppose to its 90-day low While during the day, 107.17M shares valued at 1.74 million were bought and sold.

Lexicon Pharmaceuticals, Inc. [NASDAQ:LXRX]: Analyst Rating and Earnings

Its stock price has been found in the range of 1.13 to 8.39. This is compared to its latest closing price of $3.53.

Keep your eyes peeled for this company’s upcoming financial results publication, which is slated for Wed 11 Mar (In 100 Days).

Fundamental Analysis of Lexicon Pharmaceuticals, Inc. [LXRX]

Now let’s turn to look at profitability: with a current Operating Margin for Lexicon Pharmaceuticals, Inc. [LXRX] sitting at -163.39 and its Gross Margin at +93.08, this company’s Net Margin is now 49.90%. These measurements indicate that Lexicon Pharmaceuticals, Inc. [LXRX] is generating considerably more profit, after expenses are accounted for, compared to its market peers.

This company’s Return on Total Capital is -40.00, and its Return on Invested Capital has reached -47.20%. Its Return on Equity is -938.23, and its Return on Assets is -33.02. These metrics show a mixed bag, which means that this investment’s attractiveness can be quickly increased or decreased in the short term, depending on future updates LXRX financial performance.

Similarly, its Total

Debt to Total Capital is 112.08, while its Total Debt to Total Assets stands at 84.88.

What about valuation? This company’s Enterprise Value to EBITDA is -4.62. The Enterprise Value to Sales for this firm is now 1.39, and its Total Debt to Enterprise Value stands at 0.31.

Shifting the focus to workforce efficiency, Lexicon Pharmaceuticals, Inc. [LXRX] earns $312,916 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 11.76 and its Total Asset Turnover is 0.17. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 4.59 and its Current Ratio is 4.72. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Lexicon Pharmaceuticals, Inc. [LXRX] has 107.17M shares outstanding, amounting to a total market cap of $378.31M. Its stock price has been found in the range of 1.13 to 8.39. At its current price, it has moved down by -61.92% from its 52-week high, and it has moved up 184.00% from its 52-week low.

This stock’s Beta value is currently 0.99, which indicates that it is 7.22% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 37.29. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is Lexicon Pharmaceuticals, Inc. [LXRX] a Reliable Buy?

Shares of Lexicon Pharmaceuticals, Inc. [LXRX], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.